Reason for request
Extension of indication
Clinical Benefit
| Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years. |
Clinical Added Value
| no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes. |
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
zHmwBjghemh4Hcd0
